Salah Abdeslam, the main defendant in the trial of the 13 November 2015 attacks hasÂ tested positive for Covid-19, calling into question whether the court hearings will resume on schedule. The only survivor of the jihadist group who killed 130 peopleÂ in Paris and Saint-Denis in 2015, is being held for the duration of the hearing in the Fleury-Merogis prison south of the French capital. Believed to be the largest prison in Europe, a total of 21 inmates have reportedly tested positive for Covid-19 as of 24 December. Nationwide, 370 of the estimated 70,000 prisoners have been infected with the coronavirus. ðŸ‡«ðŸ‡· FLASH | Salah #Abdeslam a Ã©tÃ© testÃ© positif au #COVID19. Son #procÃ¨s devrait cependant reprendre le 4 janvier, sauf si ses avocats demandent un report. (BFM) #SalahAbdeslam pic.twitter.com/y5jdPcfmRz A grim warning, as Paris court hears testimony on the making of a terrorist  	Paris attacks 'could happen again tomorrow', warns veteran anti-terror cop Salah Abdeslam hasÂ been incarcerated under a strict regime of isolation, alone in a cell equipped with a 24-hour video surveillance system. The 2015 attacks trial,Â which opened last September, is due to resume on 4 January after a two-week break. When asked whether a postponement of the hearing would be requested, one of Salah Abdeslam's lawyers, Olivia Ronen, could not immediately respond. The special court is trying a total of 20 defendants, including 14 present at the hearing, suspected of varying degrees of involvement in the preparation of the deadliest jihadist attacks ever perpetrated in France. Daily newsletterReceive essential international news every morning Keep up to date with international news by downloading the RFI app